Name: UMIN ID:
Unique ID issued by UMIN | UMIN000043918 |
---|---|
Receipt number | R000050137 |
Scientific Title | A prospective observational study to investigate the safety of SARS-CoV-2 vaccine in patients with lung cancer who are treated or will be treated with anticancer medication (OLCSG2102) |
Date of disclosure of the study information | 2021/04/14 |
Last modified on | 2023/10/16 12:57:33 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2021/04/14 11:51:55 | ||
2 | Update | 2021/10/17 17:44:24 | Date analysis concluded |
|
3 | Update | 2022/10/15 17:57:23 | Recruitment status |
|
4 | Update | 2023/10/16 12:57:33 | Number of participants that the trial has enrolled Outcome measures |